Company / Operating Cash Flow per Share
Silo Pharma, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.85
FY2025
5-year range
-$1.11 / $0.01
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-0.85.
Based on SEC 10-K filings.
-0.85 in FY2025.
Improved from $-1.11 to $-0.85 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 22.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.85 | +22.9% |
| FY2024 | -$1.11 | -0.2% |
| FY2023 | -$1.11 | -3190.4% |
| FY2020 | -$0.03 | -389.0% |
| FY2019 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026